Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2025 ,inter alia, to consider and approve the audited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience has informed BSE that its Board of Directors will meet on July 19, 2025, at 6:00 PM at the registered office in Hyderabad. The agenda includes considering and approving the audited financial results for both the half-year and the full financial year ended March 31, 2025, along with taking note of the auditors' report. The trading window for designated persons under the Insider Trading Policy is closed from April 1, 2025, till July 21, 2025, in line with earlier intimations. This is a routine regulatory disclosure under SEBI Listing Regulations and does not contain any financial figures itself.
No immediate impact on shareholders or stock price — this is a procedural announcement. Investors should await the actual audited results on July 19, 2025, for any meaningful financial insights.